AzurRx BioPharma Inc

NASDAQ:AZRX   1:45:00 PM EDT
0.80
-0.02 (-3.03%)
Products, Regulatory

AzurRx BioPharma Activates Additional Clinical Trial Sites in Turkey

Published: 10/14/2020 12:18 GMT
AzurRx BioPharma Inc (AZRX) - Azurrx Biopharma Activates Additional Clinical Trial Sites in Turkey for Phase 2 Combination Therapy Trial of Ms1819 in Cystic Fibrosis.
Azurrx Biopharm - Has Activated Two Trial Sites in Turkey for Its Phase 2 Combination Therapy Clinical Trial to Investigate Ms1819.
Azurrx Biopharma Inc - Topline Data Expected in Q2 2021 for Phase 2 Combination Therapy Trial of Ms1819.